| 2nd Apr 2025 7:01 am |
RNS |
Additional grant funding under DEVOTE programme |
| 2nd Apr 2025 7:00 am |
RNS |
Receipt of R&D tax credit |
| 1st Apr 2025 7:00 am |
RNS |
Result of RetailBook Offer |
| 27th Mar 2025 3:30 pm |
RNS |
RetailBook Offer |
| 27th Mar 2025 3:29 pm |
RNS |
Half-year Report |
| 27th Mar 2025 3:28 pm |
RNS |
Equity Fundraise |
| 17th Mar 2025 11:04 am |
RNS |
Scottish Government testing programme investment |
| 14th Mar 2025 7:00 am |
RNS |
CYP2C19-ID Kit adopted for routine clinical use |
| 30th Dec 2024 11:54 am |
RNS |
Result of AGM |
| 27th Dec 2024 7:00 am |
RNS |
Genedrive® CYP2C19-ID Kit performance published |
| 20th Dec 2024 12:16 pm |
RNS |
Grant of Options |
| 20th Dec 2024 12:12 pm |
RNS |
Director/PDMR Shareholding |
| 5th Dec 2024 3:00 pm |
RNS |
Posting of annual report and notice of AGM |
| 29th Nov 2024 1:00 pm |
RNS |
Block listing returns |
| 29th Nov 2024 7:00 am |
RNS |
Final Results |
| 22nd Nov 2024 7:00 am |
RNS |
Notice of Results |
| 21st Nov 2024 11:06 am |
RNS |
NIHR and OLS Funding Package |
| 4th Nov 2024 1:29 pm |
RNS |
Scottish Health Technology Group publications |
| 21st Oct 2024 3:22 pm |
RNS |
Director Declaration |
| 15th Aug 2024 10:39 am |
RNS |
Director/PDMR Shareholding |
| 12th Aug 2024 7:00 am |
RNS |
First UK commercial sales of the CYP2C19-ID Kit |
| 6th Aug 2024 7:00 am |
RNS |
Directorate Change |
| 31st Jul 2024 7:00 am |
RNS |
NICE recommends CYP2C19-ID Kit in final guidance |
| 15th Jul 2024 7:00 am |
RNS |
Breakthrough Device Designation from the U.S. FDA |
| 27th Jun 2024 9:28 am |
RNS |
Short extension to NICE publication date |
| 25th Jun 2024 7:00 am |
RNS |
Holding(s) in Company |
| 24th Jun 2024 11:13 am |
RNS |
Holding(s) in Company |
| 24th Jun 2024 11:12 am |
RNS |
Holding(s) in Company |
| 24th Jun 2024 11:11 am |
RNS |
Holding(s) in Company |
| 17th Jun 2024 4:41 pm |
RNS |
Holding(s) in Company |
| 13th Jun 2024 3:22 pm |
RNS |
Holding(s) in Company |
| 11th Jun 2024 12:54 pm |
RNS |
Holding(s) in Company |
| 7th Jun 2024 11:00 am |
RNS |
Holding(s) in Company |
| 5th Jun 2024 3:45 pm |
RNS |
Holding(s) in Company |
| 5th Jun 2024 11:39 am |
RNS |
Holding(s) in Company |
| 31st May 2024 3:56 pm |
RNS |
Block listing returns |
| 31st May 2024 11:24 am |
RNS |
Result of General Meeting |
| 30th May 2024 7:00 am |
RNS |
Result of Open Offer and REX Offer |
| 24th May 2024 7:00 am |
RNS |
Initial orders of the Genedrive MT-RNR1 Products |
| 21st May 2024 11:00 am |
RNS |
Key CYP2C19-ID test performance milestone achieved |
